ATE77960T1 - Verwendung von interleukin-1 zur induzierung der bildung von multipotenten haemopoietischen zellpopulationen. - Google Patents

Verwendung von interleukin-1 zur induzierung der bildung von multipotenten haemopoietischen zellpopulationen.

Info

Publication number
ATE77960T1
ATE77960T1 AT87905329T AT87905329T ATE77960T1 AT E77960 T1 ATE77960 T1 AT E77960T1 AT 87905329 T AT87905329 T AT 87905329T AT 87905329 T AT87905329 T AT 87905329T AT E77960 T1 ATE77960 T1 AT E77960T1
Authority
AT
Austria
Prior art keywords
interleukin
cell populations
multipotent
heemopoietic
induce
Prior art date
Application number
AT87905329T
Other languages
English (en)
Inventor
David John Cosman
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE77960T1 publication Critical patent/ATE77960T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87905329T 1986-07-30 1987-07-20 Verwendung von interleukin-1 zur induzierung der bildung von multipotenten haemopoietischen zellpopulationen. ATE77960T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/891,929 US4808611A (en) 1986-07-30 1986-07-30 Use of interleukin-1 to induce development of multipotent hemopoietic cell populations
EP87905329A EP0323462B1 (de) 1986-07-30 1987-07-20 Verwendung von interleukin-1 zur induzierung der bildung von multipotenten hämopoietischen zellpopulationen
PCT/US1987/001671 WO1988000969A1 (en) 1986-07-30 1987-07-20 Use of interleukin-1 to induce development of multipotent hemopoietic cell populations

Publications (1)

Publication Number Publication Date
ATE77960T1 true ATE77960T1 (de) 1992-07-15

Family

ID=25399071

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87905329T ATE77960T1 (de) 1986-07-30 1987-07-20 Verwendung von interleukin-1 zur induzierung der bildung von multipotenten haemopoietischen zellpopulationen.

Country Status (8)

Country Link
US (1) US4808611A (de)
EP (1) EP0323462B1 (de)
JP (1) JPH01503355A (de)
AT (1) ATE77960T1 (de)
AU (1) AU615164B2 (de)
CA (1) CA1290688C (de)
DE (1) DE3780316T2 (de)
WO (1) WO1988000969A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422105A (en) * 1985-02-05 1995-06-06 Cetus Oncology Corporation Use of recombinant colony stimulating factor 1
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
US5837229A (en) * 1985-02-05 1998-11-17 Chiron Corporation Uses of recombinant colony stimulating factor-1
US5104650A (en) * 1985-02-05 1992-04-14 Cetus Corporation Uses of recombinant colony stimulating factor-1
US5186931A (en) * 1986-08-06 1993-02-16 Ajinomoto Co., Inc. Composition and method for supporting bone marrow transplantation
JPH0618781B2 (ja) * 1986-10-18 1994-03-16 中外製薬株式会社 感染症治療剤
EP0644203A1 (de) * 1988-07-29 1995-03-22 Otsuka Pharmaceutical Co., Ltd. IL-1 alpha Derivate und Arzneimittel gegen Thrombozytopenie
US5256560A (en) * 1988-10-07 1993-10-26 University Of Saskatchewan Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells
IL91923A0 (en) * 1988-10-07 1990-06-10 Univ Saskatchewan Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells
IL92234A (en) * 1988-11-09 1993-06-10 Schering Corp Pharmaceutical compositions containing ganciclovir and granulocyte macrophage colony stimulating factor for treatment of myelosuppression associated with acquired immune deficiency
AU5355790A (en) * 1989-04-19 1990-11-16 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
US5635386A (en) * 1989-06-15 1997-06-03 The Regents Of The University Of Michigan Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
US5605822A (en) * 1989-06-15 1997-02-25 The Regents Of The University Of Michigan Methods, compositions and devices for growing human hematopoietic cells
US20040181044A1 (en) * 1989-10-16 2004-09-16 Zsebo Krisztina M. Method of stimulating growth of epithelial cells by administering stem cell factor
HU220234B (hu) * 1989-10-16 2001-11-28 Amgen Inc. Eljárás stem sejtek működését befolyásoló faktorok előállitására
US6852313B1 (en) 1989-10-16 2005-02-08 Amgen Inc. Method of stimulating growth of melanocyte cells by administering stem cell factor
US7144731B2 (en) * 1989-10-16 2006-12-05 Amgen Inc. SCF antibody compositions and methods of using the same
US5132212A (en) * 1989-11-17 1992-07-21 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Scl gene, and a hematopoietic growth and differentiation factor encoded thereby
US5214133A (en) * 1989-11-17 1993-05-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services SCL: a hematopoietic growth and differentiation factor
GB9001625D0 (en) * 1990-01-24 1990-03-21 Ciba Geigy Ag A pharmaceutical preparation for maturation of prothymocytes
WO1991012849A1 (en) * 1990-02-27 1991-09-05 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Engrafting allogeneic tissues or organs using interleukin
GB9010356D0 (en) * 1990-05-09 1990-06-27 Ciba Geigy Ag Maturation of hemopoietic cells
WO1992002822A1 (en) * 1990-08-06 1992-02-20 Cetus Corporation Methods for the identification of cytokine convertase inhibitors
US5075288A (en) * 1990-09-05 1991-12-24 The University Of Tennessee Research Corporation Somnogenic fragment of interleukin-1β
US5460964A (en) * 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
US5436151A (en) * 1992-04-03 1995-07-25 Regents Of The University Of Minnesota Method for culturing human hematopoietic stem cells in vitro
US5766951A (en) * 1992-11-12 1998-06-16 Quality Biological, Inc. Serum-free medium supporting growth and proliferation of normal bone marrow cells
US5815701A (en) * 1995-06-29 1998-09-29 Philips Electronics North America Corporation Computer method and apparatus which maintains context switching speed with a large number of registers and which improves interrupt processing time
US5945337A (en) 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US20020132017A1 (en) * 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
US6084060A (en) * 1996-12-09 2000-07-04 Imclone Systems Incorporated Composition and method for preserving progenitor cells
US6991794B1 (en) 1997-06-24 2006-01-31 Imclone Systems Incorporated Progenitor cell preservation factors and methods for and products of their use
US6310195B1 (en) * 1997-06-24 2001-10-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor
US20020034819A1 (en) * 1998-02-23 2002-03-21 Alan K. Smith Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
CA2439297A1 (en) * 2001-02-27 2002-09-06 Phylogix Llc Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues
EP1509595A4 (de) * 2001-07-05 2006-02-22 Phylogix Inc Verfahren zur isolierung dendritischer zellen
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU595864B2 (en) * 1986-03-14 1990-04-12 Otsuka Pharmaceutical Co., Ltd. Il-1 alpha derivatives and drugs
JP2579981B2 (ja) * 1986-05-06 1997-02-12 ジェネティックス・インスチチュート・インコーポレーテッド Ｍ―ｃｓｆの生産方法
AU601173B2 (en) * 1987-03-06 1990-09-06 Higuchi, Yoshinari Il-beta derivatives and drugs

Also Published As

Publication number Publication date
AU7802287A (en) 1988-02-24
DE3780316D1 (de) 1992-08-13
JPH01503355A (ja) 1989-11-16
AU615164B2 (en) 1991-09-26
US4808611A (en) 1989-02-28
EP0323462B1 (de) 1992-07-08
DE3780316T2 (de) 1992-12-24
CA1290688C (en) 1991-10-15
EP0323462A4 (de) 1989-11-30
EP0323462A1 (de) 1989-07-12
WO1988000969A1 (en) 1988-02-11

Similar Documents

Publication Publication Date Title
ATE77960T1 (de) Verwendung von interleukin-1 zur induzierung der bildung von multipotenten haemopoietischen zellpopulationen.
DE68919449D1 (de) Herstellung von IBDV in kontinuierlichen Zellinien.
DE3381675D1 (de) Einverleibung von polymeren in biologischen implantierbaren geweben zum hemmen von verkalkung.
DE3683734D1 (de) Stabiles silanolhaftgrundmittel zur verwendung in der zahnheilkunde.
DE3382390D1 (de) Zellinien und ihre verwendung in der herstellung von proteinen.
DE3674481D1 (de) Geraet zur herstellung von abdruckmassen.
DE3685503D1 (de) Elektrode zur anwendung in der elektroretinografie.
DE3689555D1 (de) Herstellung von aliphatischen Polyaminen.
DE3780618D1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
KR880700932A (ko) 다이아몬드 특성 평가 방법
BR8401001A (pt) Composicao de esmalte dental translucido adequada para aplicacao a um substrato de ceramica dental
DK497386A (da) Flydende calciumpraeparat til supplering af calciumindholdet i organismen
NL188249C (nl) Zuurstofmeetcel.
DK406287A (da) Indsatser til fastgoerelse i aabninger
DE3788796D1 (de) Serumfreies medium zur proliferation von lymphokin-aktivierten töterzellen.
NO872420D0 (no) Elektrokjemisk cellesammensetning.
DE3676604D1 (de) Expression von epa in saeugetierzellen.
DE3650395D1 (de) Gärung zur Gewinnung von d-Milchsäure.
DE3882220D1 (de) Herstellung von chlordioxyd in einer elektrolytischen zelle.
DE3670063D1 (de) Herstellung von thioantimonaten.
ES291369Y (es) Perfeccionamientos introducidos en mesas de oficina.
AT383003B (de) Ruehrmixer zur aufbereitung von guelle
ATE59407T1 (de) Expression von epa in saeugetierzellen.
DE3751059D1 (de) Verwendung von Corticosteroide zur Verringerung von postoperativen Schmerzen.
ATE87207T1 (de) Azapropazon zur praevention von post-ischaemischem gewebeschaden.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee